Imaging software developer Mirada Medical has received a new investment of 6 million pounds (7 million euros).
The investment was led by private equity healthcare firm Apposite Capital and included Mirada's founding investor, AlbionVC, and other private investors, according to Mirada.
The company said it would use the proceeds to accelerate product development milestones and improve the market accessibility of its artificial intelligence-based software applications. The software is intended to boost cancer treatment planning applications and improve personalized care.
